BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32409195)

  • 21. Lung Cancer Risk and Demographic Characteristics of Current 20-29 Pack-year Smokers: Implications for Screening.
    Pinsky PF; Kramer BS
    J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26483244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population.
    Pinsky PF; Gierada DS; Hocking W; Patz EF; Kramer BS
    Ann Intern Med; 2014 Nov; 161(9):627-33. PubMed ID: 25199624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical Care Costs Were Similar Across the Low-dose Computed Tomography and Chest X-Ray Arms of the National Lung Screening Trial Despite Different Rates of Significant Incidental Findings.
    Gareen IF; Black WC; Tosteson TD; Wang Q; Sicks JD; Tosteson ANA
    Med Care; 2018 May; 56(5):403-409. PubMed ID: 29613874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of lung cancer risk model (PLCO
    Lebrett MB; Balata H; Evison M; Colligan D; Duerden R; Elton P; Greaves M; Howells J; Irion K; Karunaratne D; Lyons J; Mellor S; Myerscough A; Newton T; Sharman A; Smith E; Taylor B; Taylor S; Walsham A; Whittaker J; Barber PV; Tonge J; Robbins HA; Booton R; Crosbie PAJ
    Thorax; 2020 Aug; 75(8):661-668. PubMed ID: 32631933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial.
    Paci E; Puliti D; Lopes Pegna A; Carrozzi L; Picozzi G; Falaschi F; Pistelli F; Aquilini F; Ocello C; Zappa M; Carozzi FM; Mascalchi M;
    Thorax; 2017 Sep; 72(9):825-831. PubMed ID: 28377492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary emphysema and coronary artery calcifications at baseline LDCT and long-term mortality in smokers and former smokers of the ITALUNG screening trial.
    Mascalchi M; Romei C; Marzi C; Diciotti S; Picozzi G; Pistelli F; Zappa M; Paci E; Carozzi F; Gorini G; Falaschi F; Deliperi AL; Camiciottoli G; Carrozzi L; Puliti D
    Eur Radiol; 2023 May; 33(5):3115-3123. PubMed ID: 36854875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of low-dose computed tomography screening on lung cancer mortality among asbestos-exposed workers.
    Barbone F; Barbiero F; Belvedere O; Rosolen V; Giangreco M; Zanin T; Pisa FE; Meduri S; Follador A; Grossi F; Fasola G
    Int J Epidemiol; 2018 Dec; 47(6):1981-1991. PubMed ID: 30325420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung Cancer Screening: Use of Low-Dose Computed Tomography.
    Martínez Pérez E; de Aguiar Quevedo K; Arrarás Martínez M; Cruz Mojarrieta J; Arana Fernández de Moya E; Barrios Benito M; Hinarejos Parga S; Cervera Deval J; Peñalver Cuesta JC
    Arch Bronconeumol (Engl Ed); 2019 Oct; 55(10):526-531. PubMed ID: 31036378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography Screening Participants.
    Pastorino U; Boffi R; Marchianò A; Sestini S; Munarini E; Calareso G; Boeri M; Pelosi G; Sozzi G; Silva M; Sverzellati N; Galeone C; La Vecchia C; Ghirardi A; Corrao G
    J Thorac Oncol; 2016 May; 11(5):693-699. PubMed ID: 26921675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study.
    Marquette CH; Boutros J; Benzaquen J; Ferreira M; Pastre J; Pison C; Padovani B; Bettayeb F; Fallet V; Guibert N; Basille D; Ilie M; Hofman V; Hofman P;
    Lancet Respir Med; 2020 Jul; 8(7):709-716. PubMed ID: 32649919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disparity in Lung Cancer Screening Among Smokers and Nonsmokers in China: Prospective Cohort Study.
    Wang L; Wang Y; Wang F; Gao Y; Fang Z; Gong W; Li H; Zhu C; Chen Y; Shi L; Du L; Li N
    JMIR Public Health Surveill; 2023 Mar; 9():e43586. PubMed ID: 36917151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidental Findings on Low-Dose CT Scan Lung Cancer Screenings and Deaths From Respiratory Diseases.
    Pinsky PF; Lynch DA; Gierada DS
    Chest; 2022 Apr; 161(4):1092-1100. PubMed ID: 34838524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness.
    Goulart BH; Bensink ME; Mummy DG; Ramsey SD
    J Natl Compr Canc Netw; 2012 Feb; 10(2):267-75. PubMed ID: 22308519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers.
    Kang HR; Cho JY; Lee SH; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Lee CT
    J Thorac Oncol; 2019 Mar; 14(3):436-444. PubMed ID: 30445189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence to general medical checkup and cancer screening guidelines according to self-reported smoking status: Korea National Health and Nutrition Examination Survey (KNHANES) 2010-2012.
    Kim EY; Shim YS; Kim YS; Lee SP; Ko KD; Choi WJ
    PLoS One; 2019; 14(10):e0224224. PubMed ID: 31639166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial.
    Pastorino U; Boeri M; Sestini S; Sabia F; Milanese G; Silva M; Suatoni P; Verri C; Cantarutti A; Sverzellati N; Corrao G; Marchianò A; Sozzi G
    Ann Oncol; 2022 Apr; 33(4):395-405. PubMed ID: 35091076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-world Clinical Implementation of Lung Cancer Screening-Evaluating Processes to Improve Screening Guidelines-Concordance.
    Carroll NM; Burnett-Hartman AN; Joyce CA; Kinnard W; Harker EJ; Hall V; Steiner JS; Blum-Barnett E; Ritzwoller DP
    J Gen Intern Med; 2020 Apr; 35(4):1143-1152. PubMed ID: 31974902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study.
    Chang GC; Chiu CH; Yu CJ; Chang YC; Chang YH; Hsu KH; Wu YC; Chen CY; Hsu HH; Wu MT; Yang CT; Chong IW; Lin YC; Hsia TC; Lin MC; Su WC; Lin CB; Lee KY; Wei YF; Lan GY; Chan WP; Wang KL; Wu MH; Tsai HH; Chian CF; Lai RS; Shih JY; Wang CL; Hsu JS; Chen KC; Chen CK; Hsia JY; Peng CK; Tang EK; Hsu CL; Chou TY; Shen WC; Tsai YH; Tsai CM; Chen YM; Lee YC; Chen HY; Yu SL; Chen CJ; Wan YL; Hsiung CA; Yang PC;
    Lancet Respir Med; 2024 Feb; 12(2):141-152. PubMed ID: 38042167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of lung cancer incidence on the low-dose computed tomography arm of the National Lung Screening Trial: A dynamic Bayesian network.
    Petousis P; Han SX; Aberle D; Bui AA
    Artif Intell Med; 2016 Sep; 72():42-55. PubMed ID: 27664507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving selection criteria for lung cancer screening. The potential role of emphysema.
    Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ
    Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.